Different miRNA expression profiles between human breast cancer tumors and serum

A bunch of microRNAs (miRNAs) have been demonstrated to be aberrantly expressed in cancer tumor tissue and serum. The miRNA signatures identified from the serum samples could serve as potential noninvasive diagnostic markers for breast cancer. The role of the miRNAs in cancerigenesis is unclear. In this study, we generated the expression profiles of miRNAs from the paired breast cancer tumors, normal, tissue, and serum samples from eight patients using small RNA-sequencing. Serum samples from eight healthy individuals were used as normal controls. We identified total 174 significantly differentially expressed miRNAs between tumors and the normal tissues, and 109 miRNAs between serum from patients and serum from healthy individuals. There are only 10 common miRNAs. This suggests that only a small portion of tumor miRNAs are released into serum selectively. Interestingly, the expression change pattern of 28 miRNAs is opposite between breast cancer tumors and serum. Functional analysis shows that the differentially expressed miRNAs and their target genes form a complex interaction network affecting many biological processes and involving in many types of cancer such as prostate cancer, basal cell carcinoma, acute myeloid leukemia, and more.

[1]  S. Griffiths-Jones,et al.  miRBase: microRNA Sequences and Annotation , 2010, Current protocols in bioinformatics.

[2]  Bing Li,et al.  The effects of CD59 gene as a target gene on breast cancer cells. , 2011, Cellular immunology.

[3]  T. Blondal,et al.  Assessing sample and miRNA profile quality in serum and plasma or other biofluids. , 2013, Methods.

[4]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[5]  Peter A. Pinto,et al.  Comprehensive microRNA Profiling of Prostate Cancer , 2013, Journal of Cancer.

[6]  Evelyn Wenkel,et al.  Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection , 2012, PloS one.

[7]  M. D. Boer,et al.  Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia , 2011, Leukemia.

[8]  N. S. Asli,et al.  MicroRNAs in organogenesis and disease. , 2008, Current molecular medicine.

[9]  E. Kroh,et al.  Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies , 2011, Cancer Prevention Research.

[10]  De-Pei Liu,et al.  MicroRNAs: key participants in gene regulatory networks. , 2003, Current opinion in chemical biology.

[11]  Joaquín Dopazo,et al.  NOIseq: a RNA-seq differential expression method robust for sequencing depth biases , 2012 .

[12]  V. Ambros,et al.  Role of MicroRNAs in Plant and Animal Development , 2003, Science.

[13]  V. Treviño,et al.  Differential expression of miR‐21, miR‐125b and miR‐191 in breast cancer tissue , 2013, Asia-Pacific journal of clinical oncology.

[14]  M. Martínez-Larrad,et al.  Serum Circulating microRNA Profiling for Identification of Potential Type 2 Diabetes and Obesity Biomarkers , 2013, PloS one.

[15]  Lucy Pigati,et al.  MicroRNAs are exported from malignant cells in customized particles , 2012, Nucleic acids research.

[16]  M. L. Hastings,et al.  Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells , 2010, PloS one.

[17]  S. Pinder,et al.  Loss of CD59 expression in breast tumours correlates with poor survival , 2003, The Journal of pathology.

[18]  G. Parmiani,et al.  Tumor-released microvesicles as vehicles of immunosuppression. , 2007, Cancer research.

[19]  Shuai Li,et al.  MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. , 2013, Pathology, research and practice.

[20]  W. McCombie,et al.  Discovery of Novel Human Breast Cancer MicroRNAs from Deep Sequencing Data by Analysis of Pri-MicroRNA Secondary Structures , 2011, PloS one.

[21]  Li Guo,et al.  Identification and characterization of microRNAs expressed in human breast cancer T-47D cells in response to prolactin treatment by Solexa deep-sequencing technology. , 2013, Biochemical and biophysical research communications.

[22]  Cristina Rodríguez-Padilla,et al.  Serum Circulating microRNA Profiling for Identification of Potential Breast Cancer Biomarkers , 2013, Disease markers.

[23]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[24]  Tian Wang,et al.  Screening of microRNA in patients with esophageal cancer at same tumor node metastasis stage with different prognoses. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[25]  P. Tan,et al.  Identification of Circulating MicroRNA Signatures for Breast Cancer Detection , 2013, Clinical Cancer Research.

[26]  Holger Sültmann,et al.  Serum microRNAs as non-invasive biomarkers for cancer , 2010, Molecular Cancer.

[27]  J. Lötvall,et al.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.

[28]  Huiyong Shen,et al.  MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells. , 2012, Biochemical and biophysical research communications.

[29]  Antoine M. van Oijen,et al.  Real-time single-molecule observation of rolling-circle DNA replication , 2009, Nucleic acids research.

[30]  A. Jemal,et al.  Breast Cancer Statistics , 2013 .

[31]  Axel Benner,et al.  Circulating microRNAs in plasma as early detection markers for breast cancer , 2013, International journal of cancer.

[32]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[33]  C. Bandala,et al.  miR-485 acts as a tumor suppressor by inhibiting cell growth and migration in breast carcinoma T47D cells. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[34]  Tongbin Li,et al.  miRecords: an integrated resource for microRNA–target interactions , 2008, Nucleic Acids Res..

[35]  Ava Kwong,et al.  Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection , 2013, PloS one.

[36]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[37]  Ze-Guang Han,et al.  Genome-Wide Identification of Schistosoma japonicum MicroRNAs Using a Deep-Sequencing Approach , 2009, PloS one.

[38]  Keith W. Jones,et al.  Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures , 2011, PloS one.

[39]  S. Meri,et al.  Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. , 1990, Immunology.

[40]  A. Luo,et al.  MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1 , 2013, Oncogene.

[41]  Lei Chen,et al.  MicroRNAome of Porcine Pre- and Postnatal Development , 2010, PloS one.

[42]  A. Jemal,et al.  Breast cancer statistics, 2013 , 2014, CA: a cancer journal for clinicians.

[43]  David I. K. Martin,et al.  Deep Sequencing Reveals Novel MicroRNAs and Regulation of MicroRNA Expression during Cell Senescence , 2011, PloS one.

[44]  Yadong Wang,et al.  miR2Disease: a manually curated database for microRNA deregulation in human disease , 2008, Nucleic Acids Res..

[45]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[46]  Gene W. Yeo,et al.  Deep sequencing identifies new and regulated microRNAs in Schmidtea mediterranea. , 2009, RNA.

[47]  Ana Kozomara,et al.  miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..

[48]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[49]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[50]  Yong Zhao,et al.  A developmental view of microRNA function. , 2007, Trends in biochemical sciences.

[51]  Graham Ball,et al.  Identification and Validation of Oncologic miRNA Biomarkers for Luminal A-like Breast Cancer , 2014, PloS one.

[52]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[53]  Wenlin Huang,et al.  miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. , 2011, Cancer research.